India Medical Devices Market Size to Hit $31.85 Billion by 2034 (5.83% CAGR) | Key Growth Drivers

A Paradigm Shift in the MedTech Landscape: Strategic Overview

The healthcare ecosystem in India is currently witnessing a structural transformation, transitioning from a service-driven model to a technology-intensive infrastructure. At the core of this evolution is the medical technology (MedTech) sector, which has emerged as one of the most dynamic industrial categories in the country. Driven by a massive population base, an escalating burden of non-communicable diseases, and proactive government interventions, the India Medical Devices Market Size is reaching unprecedented heights. This development positions India not just as a high-consumption market but as a burgeoning global hub for medical device manufacturing and R&D.

According to the latest comprehensive research by IMARC Group, the India medical devices market reached a significant valuation of USD 19.11 Billion in 2025. This valuation reflects a robust sector that is rapidly integrating advanced diagnostic and therapeutic solutions into the national healthcare fabric. Moving forward, the industry is on a trajectory of sustained capital expansion, projected to reach USD 31.85 Billion by 2034, expanding at a steady Compound Annual Growth Rate (CAGR) of 5.83% during the 2026-2034 forecast period.

Request a Business Sample Report for Procurement & Investment Evaluation: https://www.imarcgroup.com/india-medical-devices-market/requestsample

Key Growth Drivers of the Indian MedTech Sector

The expansion of the India Medical Devices Market Size is anchored by five critical structural drivers:

1. Favorable Government Policies and PLI Schemes: The "National Medical Devices Policy 2023" and the Production Linked Incentive (PLI) schemes have been instrumental in boosting local production. By reducing import dependency for high-end equipment like CT and MRI scanners, these policies have encouraged both domestic players and multinationals to set up localized manufacturing units.

2. Rising Burden of Chronic and Non-Communicable Diseases (NCDs): India is facing an escalating burden of NCDs, including diabetes, cardiovascular disorders, and cancer. This demographic shift is directly fueling the demand for precision-driven diagnostic, monitoring, and therapeutic equipment required for long-term disease management.

3. Digital Health and AI Integration: The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) is redefining clinical workflows. AI-powered diagnostic tools are enabling faster and more accurate results, while remote patient monitoring devices are expanding healthcare access to previously underserved regions.

4. Expansion of Private Healthcare Infrastructure: The rapid growth of the private hospital sector, supported by significant FDI inflows, has led to the establishment of world-class specialty centers. In 2025, major investments, such as Wipro GE Healthcare's $960 million plan, underscored global confidence in India's capacity to absorb advanced medical technology.

5. Booming Medical Tourism: India's cost-advantaged high-end procedures-such as cardiac surgeries and organ transplants-attract thousands of international patients annually. This creates a steady institutional demand for state-of-the-art surgical and monitoring devices to maintain international standards of care.

India Medical Devices Market Segmentation

The market is categorized into several distinct segments, each reflecting the specific clinical requirements and infrastructural capabilities of the Indian healthcare system.

1. By Product Type: Orthopedic Devices Lead

• Orthopedic Devices (Leading Segment - 18% Share): This segment holds the largest share due to the rising incidence of musculoskeletal disorders and a significant surge in joint replacement surgeries among the aging population.
• Diagnostic Imaging: Including MRI, CT scanners, and ultrasound systems, which are seeing high demand as diagnostic chains expand into Tier-2 and Tier-3 cities.
• Cardiovascular Devices: Fueled by the high prevalence of heart-related ailments and the increasing availability of specialized cardiac centers.
• In-Vitro Diagnostics (IVD): Accelerating through the rise of preventive screening, wellness packages, and point-of-care testing.
• Others: Including Dental Devices, Ophthalmic Devices, and Wound Management products.

2. By End User: Hospitals and ASCs at the Forefront

• Hospitals and Ambulatory Surgery Centers (Leading Segment - 70% Share): This segment remains the primary revenue generator. The rapid expansion of private hospital groups and specialty surgery centers requires advanced medical infrastructure to manage high patient volumes and complex procedures.
• Clinics: Small and medium-sized clinics are increasingly adopting portable diagnostic tools to provide localized care.

3. By Region: South India's Strategic Dominance

• South India (Leading Segment - 34% Share): This region benefits from a well-established MedTech ecosystem, featuring major healthcare institutions, export-oriented logistics, and engineering clusters in cities like Bengaluru, Chennai, and Hyderabad.
• North, West, and East India: These regions are witnessing rapid growth due to increasing government investments in healthcare infrastructure and a rising number of private specialty hospitals in the NCR and Mumbai regions.

Industry Challenges and Market Dynamics

Despite the optimistic outlook, the industry must navigate significant hurdles. Currently, India relies on imports for a large portion of its high-end diagnostic imaging and radiation therapy equipment. High custom duties and currency fluctuations can often lead to inflated costs for these critical tools. Additionally, while the regulatory transition under the Central Drugs Standard Control Organisation (CDSCO) has improved quality standards, it has also increased the compliance burden for small-scale domestic manufacturers.

However, the trend toward "Home Healthcare" is providing a new revenue stream. There is a growing consumer preference for portable and patient-centric devices, such as wearable ECG monitors and continuous glucose monitors (CGM), as personalized healthcare becomes a mainstream trend.

Ask Analyst for Custom Research Report: https://www.imarcgroup.com/request?type=report&id=32628&flag=E

Competitive Landscape & Key Player Positioning:

Covering an in-depth analysis of the competitive landscape, market structure, key player positioning, competitive dashboards, top winning strategies, and detailed profiles of all major industry participants-you will gain access to all these exclusive insights within the full research report.

Frequently Asked Questions (FAQs)

1. What is the current India Medical Devices Market Size?

According to IMARC Group, the market was valued at USD 19.11 Billion in 2025.

2. What is the projected growth rate (CAGR) for the market?

The market is expected to grow at a CAGR of 5.83% during the 2026-2034 forecast period, reaching USD 31.85 Billion.

3. Which product category holds the largest share?

Orthopedic Devices lead the market with an 18% share, followed by diagnostic imaging and cardiovascular devices.

4. Which region is the leader in the India medical devices market?

South India currently leads the regional market with a 34% share, supported by strong healthcare infrastructure in cities like Bengaluru and Chennai.

5. How are hospitals influencing the market size?

Hospitals and ASCs are the primary end users, accounting for 70% of the market, as they invest heavily in advanced surgical and diagnostic technology.

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.